Huanzhang Ding

机构：Fuyang Normal University

发表论文 13 篇 · 总被引 87 次 · h-index 5

代表论文

• Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway (2017 · Cellular Physiology and Biochemistry · 被引 26)
• Comparative analysis of immune function, hemorheological alterations and prognosis in colorectal cancer patients with different traditional Chinese medicine syndromes (2017 · Cancer Biomarkers · 被引 15)
• Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024) (2025 · Journal of Evidence-Based Medicine · 被引 13)
• Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and ‘frequent exacerbator’ phenotype (2024 · Molecular Medicine Reports · 被引 11)
• Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD (2017 · Bioscience Reports · 被引 9)
• Effect of Liuweibuqi capsules on CD4+CD25+Foxp3+ regulatory T cells, helper T cells and lung function in patients with stable chronic obstructive pulmonary disease complicated with lung Qi deficiency (2018 · Journal of Thoracic Disease · 被引 5)